Normal view MARC view ISBD view

Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor: A novel treatment option for nurse practitioners treating patients with psoriatic disease.

Young, Melodie

Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor: A novel treatment option for nurse practitioners treating patients with psoriatic disease. [electronic resource] - Journal of the American Association of Nurse Practitioners Dec 2016 - 683-695 p. digital

Publication Type: Journal Article

ISSN: 2327-6924

Standard No.: 10.1002/2327-6924.12428 doi

Subjects--Topical Terms:
Adult
Arthritis, Psoriatic--drug therapy
Female
Humans
Male
Middle Aged
Nurse Practitioners--education
Phosphodiesterase 4 Inhibitors--pharmacology
Thalidomide--adverse effects

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)